JP2023179752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023179752A5 JP2023179752A5 JP2023180474A JP2023180474A JP2023179752A5 JP 2023179752 A5 JP2023179752 A5 JP 2023179752A5 JP 2023180474 A JP2023180474 A JP 2023180474A JP 2023180474 A JP2023180474 A JP 2023180474A JP 2023179752 A5 JP2023179752 A5 JP 2023179752A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- linker
- peptide
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169072.2 | 2016-05-10 | ||
| EP16169072 | 2016-05-10 | ||
| EP17154452 | 2017-02-02 | ||
| EP17154452.1 | 2017-02-02 | ||
| JP2018559205A JP7537074B2 (ja) | 2016-05-10 | 2017-05-10 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
| PCT/EP2017/061151 WO2017194586A1 (en) | 2016-05-10 | 2017-05-10 | Agents that activate cd47 and their use in the treatment of inflammation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559205A Division JP7537074B2 (ja) | 2016-05-10 | 2017-05-10 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023179752A JP2023179752A (ja) | 2023-12-19 |
| JP2023179752A5 true JP2023179752A5 (https=) | 2024-04-08 |
| JP7822577B2 JP7822577B2 (ja) | 2026-03-03 |
Family
ID=58772857
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559205A Active JP7537074B2 (ja) | 2016-05-10 | 2017-05-10 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
| JP2022035726A Pending JP2022078244A (ja) | 2016-05-10 | 2022-03-08 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
| JP2023180474A Active JP7822577B2 (ja) | 2016-05-10 | 2023-10-19 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559205A Active JP7537074B2 (ja) | 2016-05-10 | 2017-05-10 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
| JP2022035726A Pending JP2022078244A (ja) | 2016-05-10 | 2022-03-08 | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11142548B2 (https=) |
| EP (1) | EP3454884B1 (https=) |
| JP (3) | JP7537074B2 (https=) |
| CA (1) | CA3023802C (https=) |
| WO (1) | WO2017194586A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3023802C (en) * | 2016-05-10 | 2025-02-04 | Inserm (Institut De La Sante Et De La Recherche Medicale) | ACTIVATING AGENTS OF THE DIFFERENTIATION CLUSTER 47 FOR USE IN THE TREATMENT OF INFLAMMATION |
| EP3737370A4 (en) * | 2018-01-09 | 2021-12-15 | Brigham Young University | COMPOSITIONS AND METHODS OF TREATMENT OF PAIN WITH WOGONIN |
| JPWO2022113887A1 (https=) * | 2020-11-27 | 2022-06-02 | ||
| EP4329825A4 (en) * | 2021-04-26 | 2025-03-26 | President and Fellows of Harvard College | CD47 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE EYE DISEASES |
| CN116831988A (zh) * | 2023-06-13 | 2023-10-03 | 南京鼓楼医院 | 一种载肽模拟物pkhb1的脂质体眼用制剂及其制备方法 |
| WO2026062098A1 (fr) | 2024-09-18 | 2026-03-26 | Sorbonne Universite | Nouvelles protéines activatrices de cd47 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| DE69232137T2 (de) | 1991-11-25 | 2002-05-29 | Enzon Inc | Multivalente antigen-bindende proteine |
| US6001962A (en) | 1996-11-15 | 1999-12-14 | The Regents Of The University Of California | Modified Fas ligands |
| CA2226962A1 (en) | 1998-02-16 | 1999-08-16 | Marie Sarfati | Use of binding agents to cd47 and its ligands in the treatment or the prophylaxis of various inflammatory, autoimmune and allergic diseases and in the treatment of graft rejection |
| DE69938451T2 (de) | 1998-06-18 | 2009-04-09 | Imed Ab | Fas peptide und antikörper zur modulierung von apoptosis |
| JP5431151B2 (ja) | 2006-07-13 | 2014-03-05 | ユニバーシティー オブ アイオワ リサーチ ファンデーション | 血管障害および加齢黄斑変性症の治療および診断のための方法および試薬 |
| US20110237498A1 (en) * | 2008-12-19 | 2011-09-29 | Novartis Ag | Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| CA2766039A1 (en) | 2009-06-29 | 2011-01-20 | The Board Of Regents Of The University Of Texas System | Arginase formulations and methods |
| EP2563359A1 (en) | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| HRP20221260T1 (hr) | 2010-05-14 | 2023-03-03 | The Board Of Trustees Of The Leland Stanford Junior University | Humanizirana i kimerna monoklonska protutijela za cd47 |
| US20140127269A1 (en) | 2012-02-13 | 2014-05-08 | The Schepens Eye Research Institute, Inc. | Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof |
| CN104519898A (zh) | 2012-06-06 | 2015-04-15 | 国家健康与医学研究院 | 用于治疗癌症的方法和药物组合物 |
| WO2014060517A1 (en) | 2012-10-17 | 2014-04-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (amd) |
| PL3087182T3 (pl) | 2013-12-23 | 2019-11-29 | Memorial Sloan Kettering Cancer Center | Sposoby i kompozycje do leczenia raka wykorzystujące środki oparte na kwasie peptydonukleinowym |
| EP2898896A1 (en) * | 2014-01-22 | 2015-07-29 | Université Pierre et Marie Curie (Paris 6) | Agents for use in the treatment of retinal inflammation |
| JP6613304B2 (ja) | 2014-09-17 | 2019-12-04 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 抗ｃｄ２７６抗体（ｂ７ｈ３） |
| WO2016061133A1 (en) | 2014-10-14 | 2016-04-21 | Riptide Bioscience, Inc. | Peptides having anti-inflammatory properties |
| FR3036620B1 (fr) * | 2015-05-27 | 2017-09-01 | Inst Biophytis | Utilisation de 3-desoxyanthocyanidines pour le traitement de maladies oculaires |
| CA3023802C (en) * | 2016-05-10 | 2025-02-04 | Inserm (Institut De La Sante Et De La Recherche Medicale) | ACTIVATING AGENTS OF THE DIFFERENTIATION CLUSTER 47 FOR USE IN THE TREATMENT OF INFLAMMATION |
-
2017
- 2017-05-10 CA CA3023802A patent/CA3023802C/en active Active
- 2017-05-10 EP EP17725893.6A patent/EP3454884B1/en active Active
- 2017-05-10 WO PCT/EP2017/061151 patent/WO2017194586A1/en not_active Ceased
- 2017-05-10 US US16/300,438 patent/US11142548B2/en active Active
- 2017-05-10 JP JP2018559205A patent/JP7537074B2/ja active Active
-
2022
- 2022-03-08 JP JP2022035726A patent/JP2022078244A/ja active Pending
-
2023
- 2023-10-19 JP JP2023180474A patent/JP7822577B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023179752A5 (https=) | ||
| JP2025063029A5 (https=) | ||
| JP2018171063A5 (https=) | ||
| Zhao et al. | Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. | |
| JP2019122392A5 (https=) | ||
| Vitali | Proline-rich peptides: Multifunctional bioactive molecules as new potential therapeutic drugs | |
| CN112119085A (zh) | 稳定肽-介导的靶向蛋白降解 | |
| JP2018515085A5 (https=) | ||
| JP2012520059A5 (https=) | ||
| JP2018536405A5 (https=) | ||
| CA2412278A1 (en) | Polymer-modified synthetic proteins | |
| JP2023029902A5 (https=) | ||
| JP2018538356A5 (https=) | ||
| JP2022126804A5 (https=) | ||
| AU2002365196B8 (en) | Multimeric proteins and methods of making and using same | |
| AU2009312892A1 (en) | Neuropeptide-2-receptor (Y-2r) agonists and uses thereof | |
| CN110461861A (zh) | 人参肽和人参肽类似肽的制备和利用 | |
| JP2022500409A5 (https=) | ||
| JP2019521963A5 (https=) | ||
| JP2026035742A5 (https=) | ||
| JP2014517690A5 (https=) | ||
| EP1756160B1 (en) | Oligomeric peptides and their use for the treatment of hiv infections | |
| JP2017036294A (ja) | 非ペプチドヒンジ部含有フレキシブル抗体様分子 | |
| CN103755810B (zh) | 一种长效hiv‐1膜融合抑制剂 | |
| JP2020127419A5 (https=) |